The Food and Drug Administration announced Friday that it is proposing to establish a maximum level of arsenic acceptable in apple juice. The threshold, 10 parts per billion, is the same as the Environmental Protection Agency’s requirement for drinking water.
The agency will accept public comments on the proposed action for 60 days.
Nearly two years ago, reports from the TV show of Mehmet Oz, MD, and later Consumer Reports, raised alarms about the amount of arsenic appearing in apple juice. The FDA’s own subsequent investigation found that overall arsenic levels were generally below the 10 ppb threshold. Of those that were higher, the levels of inorganic arsenic — identified as a known carcinogen — were all below 10 ppb.
Organic arsenic, which is normally found in the earth’s crust, is essentially harmless, according to the agency. Continue reading →
Major Study Finds That Overall Population Health in U.S. Has Improved, But Has Not Kept Pace With Other Wealthy Nations
Americans are living longer lives but are spending more years afflicted with major illnesses such as Alzheimer’s disease, kidney disease, and mental and behavioral disorders, according to a study published online in the Journal of American Medical Association. Researchers show that the overall population health improved in the U.S. in the last few decades, however, illness and chronic disability now account for nearly half of the country’s health burden.
The objective of the study was to measure the burden of diseases, injuries and leading risk factors in the U.S. from 1990 to 2010 and to compare these measurements with the 34 countries in the Organisation for Economic Co-operation and Development (OECD). The researchers found that U.S. life expectancy for both sexes increased from 75.2 years in 1990 to 78.2 years in 2010; during the same period, healthy life expectancy increased from 65.8 years to 68.1 years. During this time period, improvements in population health in the U.S. did not keep pace with other wealthy nations. The authors note that the U.S. spends the most per capita on health care across all countries yet lags behind other high-income countries for life expectancy and many other health outcome measures.
In a recent national public opinion poll, two-thirds of Americans (66%) say that their quality of life has been improved by medical research and that the cost of health care is the most critical health issue in America today. We must continue to urge policy makers about the importance of funding medical research if we want to live healthier – not just longer – lives.
The full study is available online: http://jama.jamanetwork.com/article.aspx?articleid=1710486
Editor’s Note: This study is supported in part by the Intramural Program of the National Institutes of Health, the National Institute of Environmental Health Sciences, and in part by the Bill and Melinda Gates Foundation.
By Sara J. Chang, Government Relations and Public Policy Manager, Lupus Foundation of America.
“We are lupus activists, and we’re here to tell our stories and make our voices heard throughout Capitol Hill!” That was the empowerment felt during the Lupus Foundation of America’s biennial National Lupus Advocacy Summit held June 24-25, 2013. It is always an energizing and rewarding event for our lupus activists and 2013 was no exception. We had meetings with 176 Congressional offices, involving 220 people representing 30 states. Our online activists also came out in force, generating 3,503 emails and phone calls to Congress during the two-day event!
We took to Capitol Hill to urge Congress to support funding the National Institutes of Health (NIH) at $32 billion and to pass H.R. 460, the Patients’ Access to Treatments Act (PATA), to ensure access to treatments for lupus and other chronic conditions. Lupus activists reinforced their request when they presented more than 30,000 petition signatures collected from individuals calling upon Congress to expand the medical research effort on lupus. (You can still sign the online petition at www.cruelmystery.org.) Continue reading →
On June 17, Research!America hosted a Capitol Hill briefing on neglected tropical diseases in partnership with Drugs for Neglected Diseases initiative (DNDi), Global Health Technologies Coalition (GHTC), The American Society for Tropical Medicine and Hygiene, and Doctors Without Borders/Médecins Sans Frontières (MSF).
Research!America also led a series of Hill meetings last week with influential congressional offices to discuss some of the successes of USAID’s NTD program and to highlight the need for continued investments. USAID’s NTD program – which was authorized by Congress in 2006 – has helped to deliver more than 580 million treatments to approximately 260 million people through mass drug administration campaigns. We were joined by Georgetown University, Baylor College of Medicine, the Global Network for NTDs, IMA World Health and the Latin America Society for Chagas (LASOCHA). The group – which represented a broad range of partners from organizations that implement USAID NTD programs to patient advocates to leading NTD expert, Dr. Peter Hotez – discussed the importance of the USAID NTD program to their work and updated staffers on emerging issues in NTD prevention and treatment. Continue reading →